Bombus terrestris chromosome 17, iyBomTerr1.2, whole genome shotgun sequence.
Bombus terrestris (buff-tailed bumblebee)
Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta; Pterygota; Neoptera; Endopterygota; Hymenoptera; Apocrita; Aculeata; Apoidea; Apidae; Bombus; Bombus.
REFSEQ INFORMATION: The reference sequence is identical to\nOU342937.1.\nAssembly name: iyBomTerr1.2\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the WELLCOME SANGER INSTITUTE on\n2022/02/09. The original whole-genome shotgun project has the\naccession CAJUYY000000000.2.\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Bombus terrestris Annotation Release\n 103\nAnnotation Version :: 103\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00026
Derived by automated computational analysis using gene prediction method: Gnomon.
uncharacterized LOC105666969, transcript variant X2
COORDINATES: polyA evidence [ECO:0006239]
uncharacterized LOC105666969, transcript variant X1
uncharacterized LOC105666969, transcript variant X4
uncharacterized LOC105666969, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
uncharacterized LOC110120225, transcript variant X1
uncharacterized LOC110120225, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC110120225, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
uncharacterized LOC110120225, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC100648349, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
uncharacterized LOC100648349, transcript variant X1
uncharacterized LOC100648349, transcript variant X3
histone-lysine N-methyltransferase SETMAR-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
venom acid phosphatase Acph-1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
venom acid phosphatase Acph-1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
uncharacterized LOC100651438, transcript variant X8
uncharacterized LOC100651438, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 47 samples with support for all annotated introns
uncharacterized LOC100651438, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized LOC100651438, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
uncharacterized LOC100651438, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
uncharacterized LOC100651438, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 56 samples with support for all annotated introns
uncharacterized LOC100651438, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC100651438, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC100651438, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC100651438, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized LOC100651438, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
calcium and integrin-binding family member 3
4-coumarate--CoA ligase 1, transcript variant X1
4-coumarate--CoA ligase 1, transcript variant X2
4-coumarate--CoA ligase 1, transcript variant X3
4-coumarate--CoA ligase 1, transcript variant X4
uncharacterized LOC125386742, transcript variant X6
uncharacterized LOC125386742, transcript variant X5
uncharacterized LOC125386742, transcript variant X11
uncharacterized LOC125386742, transcript variant X7
uncharacterized LOC125386742, transcript variant X9
uncharacterized LOC125386742, transcript variant X2
uncharacterized LOC125386742, transcript variant X10
uncharacterized LOC125386742, transcript variant X8
COORDINATES: nucleotide motif:Rfam:12.0:RF00001
uncharacterized LOC125386742, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
uncharacterized LOC125386742, transcript variant X1
uncharacterized LOC125386742, transcript variant X4
probable ATP-dependent RNA helicase Dbp73D
SET domain-containing protein SmydA-8-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
SET domain-containing protein SmydA-8-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
SET domain-containing protein SmydA-8-like isoform X1
SET domain-containing protein SmydA-8-like isoform X2
COORDINATES: nucleotide motif:Rfam:12.0:RF00619
GDP-D-glucose phosphorylase 1-like, transcript variant X6
GDP-D-glucose phosphorylase 1-like, transcript variant X2
GDP-D-glucose phosphorylase 1-like, transcript variant X4
GDP-D-glucose phosphorylase 1-like, transcript variant X5
GDP-D-glucose phosphorylase 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
GDP-D-glucose phosphorylase 1-like, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
GDP-D-glucose phosphorylase 1-like, transcript variant X3
GDP-D-glucose phosphorylase 1-like isoform X1
GDP-D-glucose phosphorylase 1-like isoform X4
GDP-D-glucose phosphorylase 1-like isoform X2
GDP-D-glucose phosphorylase 1-like isoform X3
uncharacterized LOC125386756, transcript variant X1
uncharacterized LOC125386756, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 97% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 46% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 50% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC125386618, transcript variant X2
uncharacterized LOC125386618, transcript variant X3
uncharacterized LOC125386618, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC125386733, transcript variant X1
uncharacterized LOC125386733, transcript variant X2
uncharacterized LOC125386732, transcript variant X1
uncharacterized LOC125386732, transcript variant X3
uncharacterized LOC125386734, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 48 samples with support for all annotated introns
uncharacterized LOC125386734, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
uncharacterized LOC125386732, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 25% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 44% coverage of the annotated genomic feature by RNAseq alignments
GDP-D-glucose phosphorylase 1-like, transcript variant X8
GDP-D-glucose phosphorylase 1-like, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized LOC125386741, transcript variant X1
uncharacterized LOC125386741, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 99% coverage of the annotated genomic feature by RNAseq alignments, including 42 samples with support for all annotated introns
uncharacterized LOC125386620, transcript variant X2
uncharacterized LOC125386620, transcript variant X3
uncharacterized LOC125386620, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 54% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC125386649, transcript variant X1
uncharacterized LOC125386649, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 27% coverage of the annotated genomic feature by RNAseq alignments
dynein beta chain, ciliary-like, transcript variant X1
dynein beta chain, ciliary-like, transcript variant X2
dynein beta chain, ciliary-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
uncharacterized LOC125386615, transcript variant X2
uncharacterized LOC125386615, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 23% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 25% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 68 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
GDP-D-glucose phosphorylase 1, transcript variant X10
GDP-D-glucose phosphorylase 1, transcript variant X6
GDP-D-glucose phosphorylase 1, transcript variant X2
GDP-D-glucose phosphorylase 1, transcript variant X1
GDP-D-glucose phosphorylase 1, transcript variant X3
GDP-D-glucose phosphorylase 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 108 samples with support for all annotated introns
GDP-D-glucose phosphorylase 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 84 samples with support for all annotated introns
GDP-D-glucose phosphorylase 1, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
GDP-D-glucose phosphorylase 1, transcript variant X8
GDP-D-glucose phosphorylase 1, transcript variant X7
GDP-D-glucose phosphorylase 1, transcript variant X9
uncharacterized LOC125386702, transcript variant X1
uncharacterized LOC125386702, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 27% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC125386706, transcript variant X1
uncharacterized LOC125386706, transcript variant X3
uncharacterized LOC125386713, transcript variant X2
uncharacterized LOC125386713, transcript variant X1
uncharacterized LOC125386706, transcript variant X2
uncharacterized LOC125386712, transcript variant X2
uncharacterized LOC125386712, transcript variant X3
uncharacterized LOC125386712, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 101 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 81 samples with support for all annotated introns
GDP-D-glucose phosphorylase 1 isoform X6
GDP-D-glucose phosphorylase 1 isoform X3
GDP-D-glucose phosphorylase 1 isoform X1
GDP-D-glucose phosphorylase 1 isoform X2
GDP-D-glucose phosphorylase 1 isoform X5
GDP-D-glucose phosphorylase 1 isoform X4
uncharacterized LOC125386717, transcript variant X3
uncharacterized LOC125386717, transcript variant X2
uncharacterized LOC125386717, transcript variant X1
uncharacterized LOC125386711, transcript variant X1
uncharacterized LOC125386711, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 70 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 62 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
uncharacterized LOC125386645, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
uncharacterized LOC125386645, transcript variant X2
uncharacterized LOC125386645, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 44 samples with support for all annotated introns
uncharacterized LOC125386645, transcript variant X1
uncharacterized LOC125386633, transcript variant X3
uncharacterized LOC125386633, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
uncharacterized LOC125386633, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
SET domain-containing protein SmydA-8-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 68% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC125386805, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
uncharacterized LOC125386805, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 51 samples with support for all annotated introns
dynein axonemal heavy chain 9-like, transcript variant X8
dynein axonemal heavy chain 9-like, transcript variant X7
dynein axonemal heavy chain 9-like, transcript variant X9
dynein axonemal heavy chain 9-like, transcript variant X5
dynein axonemal heavy chain 9-like, transcript variant X4
dynein axonemal heavy chain 9-like, transcript variant X6
dynein axonemal heavy chain 9-like, transcript variant X1
dynein axonemal heavy chain 9-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
dynein axonemal heavy chain 9-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
dynein axonemal heavy chain 9-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 74% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC125386788, transcript variant X1
uncharacterized LOC125386788, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 95% coverage of the annotated genomic feature by RNAseq alignments, including 53 samples with support for all annotated introns
uncharacterized LOC125386781, transcript variant X1
uncharacterized LOC125386781, transcript variant X2
trans-1,2-dihydrobenzene-1,2-diol dehydrogenase-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 94% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon; substituted 2 bases at 2 genomic stop codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: trans-1,2-dihydrobenzene-1,2-diol dehydrogenase-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 46 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 44 samples with support for all annotated introns
uncharacterized LOC125384633, transcript variant X1
uncharacterized LOC125384633, transcript variant X2
uncharacterized LOC125386647, transcript variant X1
uncharacterized LOC125386647, transcript variant X3
uncharacterized LOC125386647, transcript variant X4
uncharacterized LOC125386647, transcript variant X2
uncharacterized LOC125386647, transcript variant X5
uncharacterized LOC125386647, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 79 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 86% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC100651786, transcript variant X1
uncharacterized LOC100651786, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 75% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
putative fatty acyl-CoA reductase CG5065, transcript variant X2
putative fatty acyl-CoA reductase CG5065, transcript variant X3
putative fatty acyl-CoA reductase CG5065, transcript variant X1
uncharacterized LOC100647884, transcript variant X9
uncharacterized LOC100647884, transcript variant X5
uncharacterized LOC100647884, transcript variant X8
uncharacterized LOC100647884, transcript variant X12
uncharacterized LOC100647884, transcript variant X10
uncharacterized LOC100647884, transcript variant X11
uncharacterized LOC100647884, transcript variant X3
uncharacterized LOC100647884, transcript variant X1
uncharacterized LOC100647884, transcript variant X4
uncharacterized LOC100647884, transcript variant X2
uncharacterized LOC100647884, transcript variant X7
uncharacterized LOC100647884, transcript variant X6
putative fatty acyl-CoA reductase CG5065
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 62% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
fatty acyl-CoA reductase 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
fatty acyl-CoA reductase 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
fatty acyl-CoA reductase 1-like isoform X1
putative fatty acyl-CoA reductase CG5065 isoform X2
putative fatty acyl-CoA reductase CG5065, transcript variant X4
putative fatty acyl-CoA reductase CG5065 isoform X1
fatty acyl-CoA reductase 1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
fatty acyl-CoA reductase 1-like isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 98% coverage of the annotated genomic feature by RNAseq alignments
fatty acyl-CoA reductase 1, transcript variant X5
fatty acyl-CoA reductase 1, transcript variant X4
fatty acyl-CoA reductase 1, transcript variant X2
fatty acyl-CoA reductase 1, transcript variant X1
fatty acyl-CoA reductase 1, transcript variant X3
fatty acyl-CoA reductase 1, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins
putative fatty acyl-CoA reductase CG5065, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC125386799, transcript variant X2
uncharacterized LOC125386799, transcript variant X1
phospholipase B1, membrane-associated-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 68% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 27% coverage of the annotated genomic feature by RNAseq alignments
phospholipase B1, membrane-associated, transcript variant X2
phospholipase B1, membrane-associated, transcript variant X1
phospholipase B1, membrane-associated isoform X2
phospholipase B1, membrane-associated isoform X1
phospholipase B1, membrane-associated, transcript variant X3
phospholipase B1, membrane-associated isoform X3
phospholipase B1, membrane-associated-like, transcript variant X2
phospholipase B1, membrane-associated-like, transcript variant X1
L-allo-threonine aldolase, transcript variant X5
L-allo-threonine aldolase, transcript variant X2
L-allo-threonine aldolase, transcript variant X3
L-allo-threonine aldolase, transcript variant X4
L-allo-threonine aldolase, transcript variant X1
L-allo-threonine aldolase, transcript variant X6
uncharacterized LOC125386729, transcript variant X2
uncharacterized LOC125386729, transcript variant X1
myosin heavy chain, non-muscle, transcript variant X9
myosin heavy chain, non-muscle, transcript variant X10
myosin heavy chain, non-muscle, transcript variant X1
myosin heavy chain, non-muscle, transcript variant X3
myosin heavy chain, non-muscle, transcript variant X4
myosin heavy chain, non-muscle, transcript variant X2
myosin heavy chain, non-muscle, transcript variant X5
myosin heavy chain, non-muscle, transcript variant X6
myosin heavy chain, non-muscle, transcript variant X7
myosin heavy chain, non-muscle, transcript variant X8
myosin heavy chain, non-muscle isoform X3
myosin heavy chain, non-muscle isoform X1
myosin heavy chain, non-muscle isoform X4
myosin heavy chain, non-muscle isoform X2
myosin heavy chain, non-muscle isoform X5
myosin heavy chain, non-muscle isoform X6
myosin heavy chain, non-muscle isoform X7
myosin heavy chain, non-muscle isoform X8
myosin heavy chain, non-muscle isoform X9
myosin heavy chain, non-muscle, transcript variant X11
myosin heavy chain, non-muscle isoform X10
myosin heavy chain, non-muscle, transcript variant X12
myosin heavy chain, non-muscle isoform X11
26S proteasome non-ATPase regulatory subunit 10
guanine nucleotide-binding protein subunit beta-like protein 1, transcript variant X2
guanine nucleotide-binding protein subunit beta-like protein 1, transcript variant X1
guanine nucleotide-binding protein subunit beta-like protein 1
uncharacterized LOC125386731, transcript variant X1
uncharacterized LOC125386731, transcript variant X2
telomerase reverse transcriptase, transcript variant X6
telomerase reverse transcriptase, transcript variant X7
telomerase reverse transcriptase, transcript variant X1
telomerase reverse transcriptase, transcript variant X2
telomerase reverse transcriptase, transcript variant X5
telomerase reverse transcriptase isoform X4
telomerase reverse transcriptase isoform X1
telomerase reverse transcriptase isoform X2
telomerase reverse transcriptase isoform X3
telomerase reverse transcriptase, transcript variant X4
telomerase reverse transcriptase, transcript variant X3
uncharacterized LOC110120325, transcript variant X1
uncharacterized LOC110120325, transcript variant X2
uncharacterized LOC110120325, transcript variant X3
protein claret segregational, transcript variant X2
protein claret segregational, transcript variant X1
protein claret segregational, transcript variant X4
protein claret segregational, transcript variant X5
protein claret segregational, transcript variant X3
protein claret segregational, transcript variant X8
protein claret segregational, transcript variant X7
protein claret segregational, transcript variant X6
PHD finger-like domain-containing protein 5A
glutenin, high molecular weight subunit DX5-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 63% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC125386657, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
uncharacterized LOC125386657, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
dynein beta chain, ciliary, transcript variant X2
dynein beta chain, ciliary, transcript variant X3
dynein beta chain, ciliary, transcript variant X4
dynein beta chain, ciliary, transcript variant X5
dynein beta chain, ciliary, transcript variant X1
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: dynein beta chain, ciliary-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 16% coverage of the annotated genomic feature by RNAseq alignments
LOW QUALITY PROTEIN: uncharacterized protein LOC125386672
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 66% coverage of the annotated genomic feature by RNAseq alignments
dynein beta chain, ciliary-like, transcript variant X6
dynein beta chain, ciliary-like, transcript variant X4
dynein beta chain, ciliary-like, transcript variant X5
dynein beta chain, ciliary-like isoform X2
dynein beta chain, ciliary-like isoform X1
protein RRP5 homolog, transcript variant X2
protein RRP5 homolog, transcript variant X1
uncharacterized LOC105666672, transcript variant X2
uncharacterized LOC105666672, transcript variant X1
uncharacterized LOC105666672, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC105666671, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 67 samples with support for all annotated introns
uncharacterized LOC105666671, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 65 samples with support for all annotated introns
uncharacterized LOC105666671, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 53 samples with support for all annotated introns
uncharacterized LOC105666671, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 56% coverage of the annotated genomic feature by RNAseq alignments
dynein axonemal heavy chain 17, transcript variant X1
dynein axonemal heavy chain 17, transcript variant X3
dynein axonemal heavy chain 17, transcript variant X2
leucine-rich repeat extensin-like protein 5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
uncharacterized LOC105666669, transcript variant X4
uncharacterized LOC105666669, transcript variant X1
uncharacterized LOC105666669, transcript variant X2
uncharacterized LOC105666669, transcript variant X3
uncharacterized LOC105666669, transcript variant X5
uncharacterized LOC125386753, transcript variant X1
uncharacterized LOC125386753, transcript variant X2
uncharacterized LOC100647323, transcript variant X4
uncharacterized LOC100647323, transcript variant X5
uncharacterized LOC100647323, transcript variant X3
uncharacterized LOC100647323, transcript variant X2
uncharacterized LOC100647323, transcript variant X1
uncharacterized protein LOC100647323 isoform X1
uncharacterized protein LOC100647323 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
G-protein coupled receptor dmsr-1, transcript variant X2
G-protein coupled receptor dmsr-1, transcript variant X3
G-protein coupled receptor dmsr-1, transcript variant X1
G-protein coupled receptor dmsr-1, transcript variant X4
G-protein coupled receptor dmsr-1 isoform X1
G-protein coupled receptor dmsr-1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
elongation of very long chain fatty acids protein 6, transcript variant X3
elongation of very long chain fatty acids protein 6, transcript variant X2
elongation of very long chain fatty acids protein 6, transcript variant X1
elongation of very long chain fatty acids protein 6
zinc finger and BTB domain-containing protein 12, transcript variant X2
uncharacterized protein LOC100651778 isoform X2
uncharacterized LOC125386690, transcript variant X2
zinc finger and BTB domain-containing protein 12, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized protein LOC100651778 isoform X1
uncharacterized LOC100652096, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
uncharacterized LOC100652096, transcript variant X6
uncharacterized LOC100652096, transcript variant X5
uncharacterized LOC100652096, transcript variant X4
uncharacterized LOC100652096, transcript variant X3
uncharacterized LOC100652096, transcript variant X2
uncharacterized LOC125386690, transcript variant X1
uncharacterized LOC125386690, transcript variant X3
zinc finger and BTB domain-containing protein 12, transcript variant X3
zinc finger and BTB domain-containing protein 12 isoform X3
trafficking kinesin-binding protein milt, transcript variant X5
uncharacterized LOC110120018, transcript variant X2
uncharacterized LOC110120018, transcript variant X3
uncharacterized LOC110120018, transcript variant X1
trafficking kinesin-binding protein milt, transcript variant X2
trafficking kinesin-binding protein milt, transcript variant X1
trafficking kinesin-binding protein milt, transcript variant X3
trafficking kinesin-binding protein milt, transcript variant X4
trafficking kinesin-binding protein milt isoform X1
uncharacterized LOC105666662, transcript variant X2
uncharacterized LOC105666662, transcript variant X3
uncharacterized LOC105666662, transcript variant X1
trafficking kinesin-binding protein milt, transcript variant X6
trafficking kinesin-binding protein milt, transcript variant X8
trafficking kinesin-binding protein milt, transcript variant X7
trafficking kinesin-binding protein milt isoform X2
uncharacterized LOC125386687, transcript variant X2
uncharacterized LOC125386687, transcript variant X5
uncharacterized LOC125386687, transcript variant X3
uncharacterized LOC125386687, transcript variant X1
uncharacterized LOC125386687, transcript variant X4
glucose dehydrogenase [FAD, quinone]-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
glucose dehydrogenase [FAD, quinone]-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
glucose dehydrogenase [FAD, quinone]-like isoform X1
glucose dehydrogenase [FAD, quinone]-like isoform X2
glucose dehydrogenase [FAD, quinone]-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
glucose dehydrogenase [FAD, quinone], transcript variant X1
uncharacterized LOC105666661, transcript variant X2
uncharacterized LOC105666661, transcript variant X1
glucose dehydrogenase [FAD, quinone] isoform X1
glucose dehydrogenase [FAD, quinone], transcript variant X2
glucose dehydrogenase [FAD, quinone] isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
glucose dehydrogenase [FAD, quinone]-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA aspartic acid (anticodon GUC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
protein phosphatase 1 regulatory subunit 12A isoform X7
transfer RNA cysteine (anticodon GCA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
phosphofurin acidic cluster sorting protein 2, transcript variant X1
phosphofurin acidic cluster sorting protein 2, transcript variant X2
phosphofurin acidic cluster sorting protein 2, transcript variant X6
phosphofurin acidic cluster sorting protein 2, transcript variant X3
phosphofurin acidic cluster sorting protein 2, transcript variant X4
phosphofurin acidic cluster sorting protein 2 isoform X1
phosphofurin acidic cluster sorting protein 2 isoform X2
phosphofurin acidic cluster sorting protein 2 isoform X6
phosphofurin acidic cluster sorting protein 2 isoform X3
phosphofurin acidic cluster sorting protein 2 isoform X4
phosphofurin acidic cluster sorting protein 2, transcript variant X8
phosphofurin acidic cluster sorting protein 2, transcript variant X5
phosphofurin acidic cluster sorting protein 2 isoform X5
phosphofurin acidic cluster sorting protein 2, transcript variant X7
phosphofurin acidic cluster sorting protein 2 isoform X7
phosphofurin acidic cluster sorting protein 2 isoform X8
UPF0692 protein CG33108, transcript variant X5
UPF0692 protein CG33108, transcript variant X4
UPF0692 protein CG33108, transcript variant X1
UPF0692 protein CG33108, transcript variant X2
UPF0692 protein CG33108, transcript variant X3
DNA topoisomerase 2-binding protein 1, transcript variant X4
DNA topoisomerase 2-binding protein 1, transcript variant X1
DNA topoisomerase 2-binding protein 1, transcript variant X3
DNA topoisomerase 2-binding protein 1, transcript variant X2
DNA topoisomerase 2-binding protein 1 isoform X1
DNA topoisomerase 2-binding protein 1 isoform X3
DNA topoisomerase 2-binding protein 1 isoform X2
DNA topoisomerase 2-binding protein 1 isoform X4
uncharacterized LOC100650462, transcript variant X1
uncharacterized LOC100650462, transcript variant X2
transcriptional adapter 2B, transcript variant X2
transcriptional adapter 2B, transcript variant X1
transcriptional adapter 2B, transcript variant X3
uncharacterized LOC105666657, transcript variant X4
uncharacterized LOC105666657, transcript variant X1
dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase, transcript variant X3
dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase, transcript variant X2
dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase, transcript variant X1
dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase isoform X3
probable Dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase isoform X2
probable Dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase isoform X1
uncharacterized LOC105666657, transcript variant X3
uncharacterized LOC100649977, transcript variant X2
uncharacterized LOC100649977, transcript variant X3
uncharacterized LOC100649977, transcript variant X1
uncharacterized LOC100649977, transcript variant X5
uncharacterized LOC100649977, transcript variant X4
uncharacterized protein LOC100649977 isoform X2
uncharacterized protein LOC100649977 isoform X3
uncharacterized protein LOC100649977 isoform X1
uncharacterized protein LOC100649977 isoform X4
uncharacterized protein LOC100649977 isoform X5
uncharacterized LOC105666657, transcript variant X2
synaptonemal complex protein 1, transcript variant X2
synaptonemal complex protein 1, transcript variant X1
synaptonemal complex protein 1 isoform X1
centrosomal protein of 290 kDa isoform X2
uncharacterized LOC110120030, transcript variant X2
uncharacterized LOC110120030, transcript variant X1
transfer RNA serine (anticodon CGA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
integrator complex subunit 11, transcript variant X4
integrator complex subunit 11, transcript variant X3
integrator complex subunit 11, transcript variant X1
integrator complex subunit 11, transcript variant X2
vesicle transport protein USE1, transcript variant X1
vesicle transport protein USE1, transcript variant X3
vesicle transport protein USE1, transcript variant X5
vesicle transport protein USE1 isoform X1
vesicle transport protein USE1 isoform X3
vesicle transport protein USE1, transcript variant X2
vesicle transport protein USE1, transcript variant X4
vesicle transport protein USE1 isoform X2
vesicle transport protein USE1 isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 122 samples with support for all annotated introns
enolase-phosphatase E1, transcript variant X1
enolase-phosphatase E1, transcript variant X2
enolase-phosphatase E1, transcript variant X3
uncharacterized LOC105666653, transcript variant X6
uncharacterized LOC105666653, transcript variant X7
uncharacterized LOC105666653, transcript variant X17
uncharacterized LOC105666653, transcript variant X3
uncharacterized LOC105666653, transcript variant X8
uncharacterized LOC105666653, transcript variant X5
uncharacterized LOC105666653, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 86% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC105666653, transcript variant X11
uncharacterized LOC105666653, transcript variant X9
uncharacterized LOC105666653, transcript variant X13
uncharacterized LOC105666653, transcript variant X10
uncharacterized LOC105666653, transcript variant X12
uncharacterized LOC105666653, transcript variant X1
uncharacterized LOC105666653, transcript variant X2
uncharacterized LOC105666653, transcript variant X18
uncharacterized LOC105666653, transcript variant X16
uncharacterized LOC105666653, transcript variant X14
uncharacterized LOC105666653, transcript variant X15
uncharacterized LOC105666653, transcript variant X19
COORDINATES: nucleotide motif:Rfam:12.0:RF00286
choline-phosphate cytidylyltransferase A, transcript variant X4
choline-phosphate cytidylyltransferase A, transcript variant X2
choline-phosphate cytidylyltransferase A, transcript variant X7
choline-phosphate cytidylyltransferase A, transcript variant X1
choline-phosphate cytidylyltransferase A, transcript variant X5
choline-phosphate cytidylyltransferase A, transcript variant X3
choline-phosphate cytidylyltransferase A, transcript variant X6
choline-phosphate cytidylyltransferase A, transcript variant X8
choline-phosphate cytidylyltransferase A, transcript variant X9
choline-phosphate cytidylyltransferase A isoform X1
choline-phosphate cytidylyltransferase A isoform X2
choline-phosphate cytidylyltransferase A isoform X3
choline-phosphate cytidylyltransferase A isoform X4
cyclic nucleotide-gated cation channel alpha-3, transcript variant X14
cyclic nucleotide-gated cation channel alpha-3, transcript variant X4
cyclic nucleotide-gated cation channel alpha-3, transcript variant X1
cyclic nucleotide-gated cation channel alpha-3, transcript variant X6
cyclic nucleotide-gated cation channel alpha-3, transcript variant X5
cyclic nucleotide-gated cation channel alpha-3, transcript variant X7
cyclic nucleotide-gated cation channel alpha-3, transcript variant X3
cyclic nucleotide-gated cation channel alpha-3, transcript variant X2
cyclic nucleotide-gated cation channel alpha-3, transcript variant X10
cyclic nucleotide-gated cation channel alpha-3, transcript variant X11
cyclic nucleotide-gated cation channel alpha-3, transcript variant X12
cyclic nucleotide-gated cation channel alpha-3, transcript variant X8
cyclic nucleotide-gated cation channel alpha-3, transcript variant X9
cyclic nucleotide-gated cation channel alpha-3, transcript variant X13
cGMP-gated cation channel alpha-1 isoform X1
cyclic nucleotide-gated channel rod photoreceptor subunit alpha isoform X12
cGMP-gated cation channel alpha-1 isoform X4
cGMP-gated cation channel alpha-1 isoform X6
cGMP-gated cation channel alpha-1 isoform X8
cGMP-gated cation channel alpha-1 isoform X3
cGMP-gated cation channel alpha-1 isoform X5
cGMP-gated cation channel alpha-1 isoform X7
cGMP-gated cation channel alpha-1 isoform X9
cGMP-gated cation channel alpha-1 isoform X2
cGMP-gated cation channel alpha-1 isoform X10
cyclic nucleotide-gated cation channel alpha-3 isoform X11
cyclic nucleotide-gated cation channel alpha-3, transcript variant X15
cyclic nucleotide-gated cation channel alpha-3 isoform X13
uncharacterized LOC110120026, transcript variant X1
uncharacterized LOC110120026, transcript variant X6
uncharacterized LOC110120026, transcript variant X7
uncharacterized LOC110120026, transcript variant X2
uncharacterized LOC110120026, transcript variant X3
uncharacterized LOC110120026, transcript variant X4
uncharacterized LOC110120026, transcript variant X5
elongation factor 1alpha F2, transcript variant X1
elongation factor 1alpha F2, transcript variant X2
28S ribosomal protein S14, mitochondrial
gustatory receptor for sugar taste 64f-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 49 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
gustatory receptor for sugar taste 64f-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 51 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
gustatory receptor for sugar taste 64f-like isoform X1
gustatory receptor for sugar taste 64f-like isoform X2
gustatory receptor for sugar taste 64f-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
serine incorporator 1, transcript variant X2
serine incorporator 1, transcript variant X1
serine incorporator 1, transcript variant X4
serine incorporator 1, transcript variant X5
serine incorporator 1, transcript variant X3
extended synaptotagmin-2, transcript variant X1
extended synaptotagmin-2, transcript variant X4
extended synaptotagmin-2, transcript variant X3
extended synaptotagmin-2, transcript variant X5
extended synaptotagmin-2, transcript variant X2
uncharacterized LOC110120031, transcript variant X3
uncharacterized LOC110120031, transcript variant X6
uncharacterized LOC110120031, transcript variant X2
uncharacterized LOC110120031, transcript variant X7
uncharacterized LOC110120031, transcript variant X9
uncharacterized LOC110120031, transcript variant X5
uncharacterized LOC110120031, transcript variant X8
uncharacterized LOC110120031, transcript variant X4
uncharacterized LOC110120031, transcript variant X1
EF-hand domain-containing family member C2
protein Wnt-11b-2, transcript variant X2
protein Wnt-11b-2, transcript variant X1
protein Wnt-11b-2, transcript variant X3
protein Wnt-11b-2, transcript variant X5
protein Wnt-11b-2, transcript variant X4
isopentenyl-diphosphate Delta-isomerase 1-like; Derived by automated computational analysis using gene prediction method: BestRefSeq.
isopentenyl-diphosphate Delta-isomerase 1-like
similar to RNA sequence, mRNA (same species):RefSeq:NM_001280926.1
annotated by transcript or proteomic data
The RefSeq transcript has 1 substitution, 1 non-frameshifting indel compared to this genomic sequence; Derived by automated computational analysis using gene prediction method: BestRefSeq.
Derived by automated computational analysis using gene prediction method: BestRefSeq.
serine/threonine-protein phosphatase 5, transcript variant X1
serine/threonine-protein phosphatase 5, transcript variant X2
cancer-related nucleoside-triphosphatase homolog
SR-related and CTD-associated factor 8, transcript variant X1
SR-related and CTD-associated factor 8, transcript variant X2
SR-related and CTD-associated factor 8 isoform X2
uncharacterized LOC100645815, transcript variant X2
uncharacterized LOC100645815, transcript variant X1
uncharacterized LOC100645815, transcript variant X3
uncharacterized protein LOC100645815 isoform X1
uncharacterized protein LOC100645815 isoform X2
uncharacterized LOC100645815, transcript variant X4
uncharacterized protein LOC100645815 isoform X3
uncharacterized LOC100645425, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
uncharacterized LOC100645425, transcript variant X2
uncharacterized LOC100645425, transcript variant X1
cytochrome P450 4c3, transcript variant X3
cytochrome P450 4c3, transcript variant X2
cytochrome P450 4c3, transcript variant X1
uncharacterized LOC100645029, transcript variant X3
uncharacterized LOC100645029, transcript variant X1
uncharacterized LOC100645029, transcript variant X2
X-ray repair cross-complementing protein 5
UDP-xylose and UDP-N-acetylglucosamine transporter
katanin p60 ATPase-containing subunit A-like 1, transcript variant X3
putative uncharacterized protein DDB_G0282133, transcript variant X3
putative uncharacterized protein DDB_G0282133, transcript variant X2
putative uncharacterized protein DDB_G0282133, transcript variant X1
putative uncharacterized protein DDB_G0282133 isoform X1
putative uncharacterized protein DDB_G0282133 isoform X2
katanin p60 ATPase-containing subunit A-like 1, transcript variant X5
katanin p60 ATPase-containing subunit A-like 1, transcript variant X1
katanin p60 ATPase-containing subunit A-like 1, transcript variant X4
katanin p60 ATPase-containing subunit A-like 1, transcript variant X2
katanin p60 ATPase-containing subunit A-like 1
threonine aspartase 1, transcript variant X1
threonine aspartase 1, transcript variant X4
threonine aspartase 1, transcript variant X3
threonine aspartase 1, transcript variant X2
sentrin-specific protease 1, transcript variant X1
sentrin-specific protease 1, transcript variant X3
sentrin-specific protease 1, transcript variant X2
uncharacterized LOC100642981, transcript variant X2
uncharacterized LOC100642981, transcript variant X1
uncharacterized protein LOC100642981 isoform X2
uncharacterized protein LOC100642981 isoform X1
GATOR complex protein NPRL3, transcript variant X4
GATOR complex protein NPRL3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 82 samples with support for all annotated introns
GATOR complex protein NPRL3, transcript variant X2
GATOR complex protein NPRL3, transcript variant X3
endoribonuclease Dcr-1, transcript variant X2
endoribonuclease Dcr-1, transcript variant X1
FAU ubiquitin-like and ribosomal protein S30, transcript variant X2
FAU ubiquitin-like and ribosomal protein S30, transcript variant X3
FAU ubiquitin-like and ribosomal protein S30, transcript variant X4
FAU ubiquitin-like and ribosomal protein S30, transcript variant X1
FAU ubiquitin-like and ribosomal protein S30 isoform X1
FAU ubiquitin-like and ribosomal protein S30 isoform X2
zinc finger protein ztf-16, transcript variant X4
zinc finger protein ztf-16, transcript variant X2
zinc finger protein ztf-16, transcript variant X3
zinc finger protein ztf-16, transcript variant X1
rab proteins geranylgeranyltransferase component A 1
FAD-dependent oxidoreductase domain-containing protein 1, transcript variant X2
FAD-dependent oxidoreductase domain-containing protein 1, transcript variant X1
FAD-dependent oxidoreductase domain-containing protein 1 isoform X1
FAD-dependent oxidoreductase domain-containing protein 1 isoform X2
uncharacterized LOC105666643, transcript variant X1
uncharacterized LOC105666643, transcript variant X2
uncharacterized protein LOC105666643 isoform X1
uncharacterized protein LOC105666643 isoform X2
NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 9
uncharacterized LOC100651739, transcript variant X1
uncharacterized LOC100651739, transcript variant X2
uncharacterized LOC100651739, transcript variant X3
uncharacterized protein LOC100651739 isoform X2
uncharacterized protein LOC100651739 isoform X1
uncharacterized protein LOC100651739 isoform X3
tumor necrosis factor receptor superfamily member wengen
gamma-aminobutyric acid receptor subunit beta-like, transcript variant X7
gamma-aminobutyric acid receptor subunit beta-like, transcript variant X2
gamma-aminobutyric acid receptor subunit beta-like, transcript variant X1
gamma-aminobutyric acid receptor subunit beta-like, transcript variant X6
gamma-aminobutyric acid receptor subunit beta-like, transcript variant X4
gamma-aminobutyric acid receptor subunit beta-like, transcript variant X5
gamma-aminobutyric acid receptor subunit beta-like, transcript variant X3
gamma-aminobutyric acid receptor subunit beta-like isoform X3
gamma-aminobutyric acid receptor subunit beta-like isoform X2
gamma-aminobutyric acid receptor subunit beta-like isoform X1
gamma-aminobutyric acid receptor alpha-like
single-stranded DNA-binding protein, mitochondrial, transcript variant X3
single-stranded DNA-binding protein, mitochondrial, transcript variant X2
single-stranded DNA-binding protein, mitochondrial, transcript variant X1
single-stranded DNA-binding protein, mitochondrial
ets DNA-binding protein pokkuri, transcript variant X4
ets DNA-binding protein pokkuri, transcript variant X3
ets DNA-binding protein pokkuri, transcript variant X2
ets DNA-binding protein pokkuri, transcript variant X1
ets DNA-binding protein pokkuri, transcript variant X6
ets DNA-binding protein pokkuri, transcript variant X5
ets DNA-binding protein pokkuri isoform X1
ets DNA-binding protein pokkuri, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 76 samples with support for all annotated introns
uncharacterized protein LOC100651145 isoform X2
ubiquitin-conjugating enzyme E2 T, transcript variant X2
ubiquitin-conjugating enzyme E2 T, transcript variant X1
ubiquitin-conjugating enzyme E2 T, transcript variant X3
ubiquitin-conjugating enzyme E2 T, transcript variant X4
rho GDP-dissociation inhibitor 2, transcript variant X2
rho GDP-dissociation inhibitor 2, transcript variant X1
rho GDP-dissociation inhibitor 2 isoform X2
rho GDP-dissociation inhibitor 1 isoform X1
dynein axonemal assembly factor 5, transcript variant X2
dynein axonemal assembly factor 5, transcript variant X1
dynein axonemal assembly factor 5 isoform X2
dynein axonemal assembly factor 5 isoform X1
phosphoribosyl pyrophosphate synthase-associated protein 2
exocyst complex component 7, transcript variant X3
exocyst complex component 7, transcript variant X2
exocyst complex component 7, transcript variant X1
39S ribosomal protein L42, mitochondrial, transcript variant X2
39S ribosomal protein L42, mitochondrial, transcript variant X4
39S ribosomal protein L42, mitochondrial, transcript variant X1
39S ribosomal protein L42, mitochondrial, transcript variant X5
39S ribosomal protein L42, mitochondrial, transcript variant X3
39S ribosomal protein L42, mitochondrial, transcript variant X6
uncharacterized protein LOC100651507 isoform X1
facilitated trehalose transporter Tret1-like, transcript variant X1
facilitated trehalose transporter Tret1-like, transcript variant X2
facilitated trehalose transporter Tret1-like
39S ribosomal protein L42, mitochondrial, transcript variant X7
coiled-coil domain-containing protein 40, transcript variant X2
coiled-coil domain-containing protein 40, transcript variant X1
coiled-coil domain-containing protein 40
39S ribosomal protein L42, mitochondrial, transcript variant X8
39S ribosomal protein L42, mitochondrial isoform X2
uncharacterized LOC100650911, transcript variant X1
uncharacterized LOC100650911, transcript variant X2
uncharacterized LOC100650911, transcript variant X3
uncharacterized protein LOC100650911 isoform X1
uncharacterized protein LOC100650911 isoform X2
putative ATP-dependent RNA helicase TDRD12, transcript variant X3
putative ATP-dependent RNA helicase TDRD12, transcript variant X1
putative ATP-dependent RNA helicase TDRD12, transcript variant X2
putative ATP-dependent RNA helicase TDRD12 isoform X1
putative ATP-dependent RNA helicase TDRD12 isoform X2
putative ATP-dependent RNA helicase TDRD12 isoform X3
zinc finger protein 568, transcript variant X1
zinc finger protein 568, transcript variant X2
N-terminal Xaa-Pro-Lys N-methyltransferase 1, transcript variant X1
N-terminal Xaa-Pro-Lys N-methyltransferase 1, transcript variant X3
N-terminal Xaa-Pro-Lys N-methyltransferase 1, transcript variant X4
N-terminal Xaa-Pro-Lys N-methyltransferase 1, transcript variant X2
N-terminal Xaa-Pro-Lys N-methyltransferase 1, transcript variant X5
N-terminal Xaa-Pro-Lys N-methyltransferase 1, transcript variant X6
N-terminal Xaa-Pro-Lys N-methyltransferase 1 isoform X1
N-terminal Xaa-Pro-Lys N-methyltransferase 1 isoform X2
N-terminal Xaa-Pro-Lys N-methyltransferase 1 isoform X3
N-terminal Xaa-Pro-Lys N-methyltransferase 1 isoform X4
heparin sulfate O-sulfotransferase, transcript variant X3
heparin sulfate O-sulfotransferase, transcript variant X2
heparin sulfate O-sulfotransferase, transcript variant X1
heparin sulfate O-sulfotransferase isoform X3
heparin sulfate O-sulfotransferase isoform X2
heparin sulfate O-sulfotransferase isoform X1
AP-2 complex subunit sigma, transcript variant X2
AP-2 complex subunit sigma, transcript variant X1
cilia- and flagella-associated protein 44, transcript variant X3
cilia- and flagella-associated protein 44, transcript variant X1
cilia- and flagella-associated protein 44, transcript variant X2
cilia- and flagella-associated protein 44 isoform X2
cilia- and flagella-associated protein 44 isoform X3
cilia- and flagella-associated protein 44 isoform X1
asparagine--tRNA ligase, cytoplasmic, transcript variant X4
asparagine--tRNA ligase, cytoplasmic, transcript variant X3
asparagine--tRNA ligase, cytoplasmic, transcript variant X2
asparagine--tRNA ligase, cytoplasmic, transcript variant X1
asparagine--tRNA ligase, cytoplasmic, transcript variant X5
TATA-box-binding protein, transcript variant X2
TATA-box-binding protein, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 ESTs, 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 154 samples with support for all annotated introns
NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial, transcript variant X1
NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial, transcript variant X3
NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial, transcript variant X2
NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial isoform X1
NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial isoform X2
NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial isoform X3
sodium channel protein 60E, transcript variant X2
sodium channel protein 60E, transcript variant X1
sodium channel protein 60E, transcript variant X3
sodium channel protein 60E, transcript variant X4
sodium channel protein 60E, transcript variant X5
sodium channel protein type 2 subunit alpha isoform X5
H(+)/Cl(-) exchange transporter 5, transcript variant X3
H(+)/Cl(-) exchange transporter 5, transcript variant X2
H(+)/Cl(-) exchange transporter 5, transcript variant X1
H(+)/Cl(-) exchange transporter 5, transcript variant X5
H(+)/Cl(-) exchange transporter 5, transcript variant X4
H(+)/Cl(-) exchange transporter 5 isoform X2
H(+)/Cl(-) exchange transporter 5 isoform X1
H(+)/Cl(-) exchange transporter 5 isoform X3
uncharacterized LOC100648727, transcript variant X3
uncharacterized LOC100648727, transcript variant X1
uncharacterized LOC100648727, transcript variant X2
uncharacterized protein LOC100648727 isoform X3
uncharacterized protein LOC100648727 isoform X1
uncharacterized protein LOC100648727 isoform X2
uncharacterized LOC105666641, transcript variant X1
uncharacterized LOC105666641, transcript variant X2
uncharacterized protein LOC105666641 isoform X1
uncharacterized protein LOC105666641 isoform X2
serine-rich adhesin for platelets isoform X2
COMM domain-containing protein 3, transcript variant X3
COMM domain-containing protein 3, transcript variant X5
COMM domain-containing protein 3, transcript variant X4
COMM domain-containing protein 3, transcript variant X1
COMM domain-containing protein 3, transcript variant X2
COMM domain-containing protein 3 isoform X1
COMM domain-containing protein 3 isoform X2
uncharacterized LOC100649519, transcript variant X2
uncharacterized LOC100649519, transcript variant X1
uncharacterized protein LOC100649519 isoform X2
uncharacterized protein LOC100649519 isoform X1
uncharacterized LOC100648612, transcript variant X3
uncharacterized LOC100648612, transcript variant X2
uncharacterized LOC100648612, transcript variant X6
uncharacterized LOC100648612, transcript variant X1
uncharacterized LOC100648612, transcript variant X4
uncharacterized LOC100648612, transcript variant X5
uncharacterized protein LOC100648612 isoform X2
uncharacterized protein LOC100648612 isoform X1
ribonuclease Z, mitochondrial, transcript variant X1
ribonuclease Z, mitochondrial, transcript variant X3
ribonuclease Z, mitochondrial, transcript variant X2
ribonuclease Z, mitochondrial, transcript variant X4
ribonuclease Z, mitochondrial isoform X1
ribonuclease Z, mitochondrial isoform X2
alpha-(1,3)-fucosyltransferase 10, transcript variant X3
alpha-(1,3)-fucosyltransferase 10, transcript variant X4
alpha-(1,3)-fucosyltransferase 10, transcript variant X2
alpha-(1,3)-fucosyltransferase 10, transcript variant X5
alpha-(1,3)-fucosyltransferase 10, transcript variant X1
alpha-(1,3)-fucosyltransferase 10, transcript variant X6
alpha-(1,3)-fucosyltransferase 10, transcript variant X7
alpha-(1,3)-fucosyltransferase 10 isoform X1
alpha-(1,3)-fucosyltransferase 10 isoform X3
alpha-(1,3)-fucosyltransferase 10 isoform X5
alpha-(1,3)-fucosyltransferase 10 isoform X4
alpha-(1,3)-fucosyltransferase 10 isoform X6
alpha-(1,3)-fucosyltransferase 10 isoform X2
tubulin-specific chaperone D-like, transcript variant X2
tubulin-specific chaperone D-like, transcript variant X1
tubulin-specific chaperone D-like isoform X2
tubulin-specific chaperone D-like isoform X1
zinc finger protein 800, transcript variant X3
zinc finger protein 800, transcript variant X1
zinc finger protein 800, transcript variant X4
zinc finger protein 800, transcript variant X2
mediator of RNA polymerase II transcription subunit 14
uncharacterized LOC100643019, transcript variant X2
uncharacterized LOC100643019, transcript variant X1
uncharacterized protein LOC100643019 isoform X1
uncharacterized protein LOC100643019 isoform X2
sphingomyelin phosphodiesterase 1, transcript variant X3
sphingomyelin phosphodiesterase 1, transcript variant X1
uncharacterized LOC110120029, transcript variant X1
uncharacterized LOC110120029, transcript variant X2
sphingomyelin phosphodiesterase 1, transcript variant X2
sphingomyelin phosphodiesterase 1 isoform X1
sphingomyelin phosphodiesterase 1 isoform X2
ubiquinol-cytochrome-c reductase complex assembly factor 1, transcript variant X2
ubiquinol-cytochrome-c reductase complex assembly factor 1, transcript variant X1
ubiquinol-cytochrome-c reductase complex assembly factor 1, transcript variant X3
ubiquinol-cytochrome-c reductase complex assembly factor 1 isoform X2
ubiquinol-cytochrome-c reductase complex assembly factor 1 isoform X1
ubiquinol-cytochrome-c reductase complex assembly factor 1 isoform X3
NADH dehydrogenase (ubiquinone) complex I, assembly factor 6
low-density lipoprotein receptor-related protein 6
protein decapentaplegic, transcript variant X1
protein decapentaplegic, transcript variant X2
serine/threonine-protein phosphatase 4 catalytic subunit
ubiquitin-conjugating enzyme E2-24 kDa, transcript variant X1
ubiquitin-conjugating enzyme E2-24 kDa, transcript variant X2
glycine-rich cell wall structural protein
peptidoglycan-recognition protein 2, transcript variant X2
peptidoglycan-recognition protein 2, transcript variant X1
CD63 antigen-like, transcript variant X2
CD63 antigen-like, transcript variant X1
uncharacterized protein LOC100649282 isoform X1
transfer RNA serine (anticodon UGA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
alpha-ketoglutarate-dependent dioxygenase alkB homolog 4, transcript variant X2
alpha-ketoglutarate-dependent dioxygenase alkB homolog 4, transcript variant X1
alpha-ketoglutarate-dependent dioxygenase alkB homolog 4, transcript variant X3
alpha-ketoglutarate-dependent dioxygenase alkB homolog 4, transcript variant X4
alpha-ketoglutarate-dependent dioxygenase alkB homolog 4 isoform X2
alpha-ketoglutarate-dependent dioxygenase alkB homolog 4 isoform X1